Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report.

Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report.

Item
http://www.wikidata.org/entity/Q37317957
High-risk childhood acute lymphoblastic leukemiaLong-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia.Favorable outcome of allogeneic hematopoietic stem cell transplantation followed by post-transplant treatment with imatinib in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD.Minimal Residual Disease Evaluation in Childhood Acute Lymphoblastic Leukemia: A Clinical Evidence Review.Allogeneic transplantation for childhood ALL.Hematopoietic stem cell transplantation for children with high-risk acute lymphoblastic leukemia in first complete remission: a report from the AIEOP registry.Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group studyReview of chronic graft-versus-host disease in children after allogeneic stem cell transplantation: nursing perspective.Philadelphia chromosome-positive acute lymphoblastic leukemia in children: new and emerging treatment options.Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remission.High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol.Total body irradiation and melphalan as a conditioning regimen for children with hematological malignancies undergoing transplantation with stem cells from HLA-identical related donors.
P2860

Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report.

Item
http://www.wikidata.org/entity/Q37317957
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Allogeneic bone marrow transpl ...... s oncology group study report.
@en
Allogeneic bone marrow transpl ...... s oncology group study report.
@nl
type
label
Allogeneic bone marrow transpl ...... s oncology group study report.
@en
Allogeneic bone marrow transpl ...... s oncology group study report.
@nl
prefLabel
Allogeneic bone marrow transpl ...... s oncology group study report.
@en
Allogeneic bone marrow transpl ...... s oncology group study report.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Allogeneic bone marrow transpl ...... 's oncology group study report
@en
P2093
P2860
P304
P31
P356
10.1016/J.BBMT.2006.09.013
P433
P478
P50
P577
P5875
P698
P921
P932